Search - tctmd.com

Displaying 661 - 680 of 993

Sort: Relevancy | Date

News Daily News

FDA Approves the Optimizer Smart Implantable Pulse Generator for Heart Failure

Yael L. Maxwell

March 22, 2019

News Conference News ACC 2019

CardioMEMS Postapproval Study Linked to Reduction in Heart Failure Hospitalizations at 1 Year

Yael L. Maxwell

March 20, 2019

News Opinion Editor's Corner ACC 2019

Live From New Orleans: Days 2 and 3 at ACC 2019

Shelley Wood

March 18, 2019

News Conference News ACC 2019

COAPT Echo Substudy in HF Patients With Mitral Regurgitation Offers New Answers, and More Questions

Shelley Wood

March 17, 2019

News Daily News

HF Admissions Decline, Non-CV Hospitalizations Rise After TAVR

L.A. McKeown

March 13, 2019

News Daily News

How HF Drugs Help and Harm Female Patients: A Call for Sex-Specific Reporting

Shelley Wood

February 26, 2019

News Industry News

Amgen, Cytokinetics And Servier Announce Start Of METEORIC-HF, The Second Phase 3 Clinical Trial Of Omecamtiv Mecarbil In Patients With Heart Failure

February 25, 2019

News Daily News

‘Watchful Waiting’ Tied to Poor Long-term Outcomes in Patients With Severe AR, Analysis Suggests

L.A. McKeown

January 17, 2019

News Daily News

None of the Usual Suspects? Troponin Elevation Still Warrants Attention

Shelley Wood

January 11, 2019

News Daily News

Artificial Intelligence From ECGs May ID Asymptomatic LV Dysfunction

Todd Neale

January 09, 2019

News Daily News

MitraClip Analysis Highlights Questions of Patient Selection in Functional MR

Shelley Wood

January 04, 2019

News Features

Top News in Heart Failure: 2018

Shelley Wood

December 28, 2018

News Daily News

More Registry Data Show No Survival Advantage for Impella in Acute MI With Cardiogenic Shock

Caitlin E. Cox

December 11, 2018

News Daily News

Could RAS-Inhibitor Prescription After TAVR Improve 1-Year Outcomes?

Yael L. Maxwell

December 10, 2018

News Conference News AHA 2018

EMPA-HEART Offers Mechanistic Clues for Empagliflozin’s Cardiac Benefits

Michael O'Riordan

November 16, 2018

News Conference News AHA 2018

Rivaroxaban Lowers Thromboembolic Risk in HF Patients: COMMANDER HF

Todd Neale

November 11, 2018

News Conference News AHA 2018

Remission, Not Cure: No Weaning Off Meds for Dilated Cardiomyopathy Patients, Says TRED-HF

Shelley Wood

November 11, 2018

News Conference News AHA 2018

PIONEER-HF: Sacubitril/Valsartan Safe and Effective in Acute Decompensated Heart Failure

Michael O'Riordan

November 11, 2018

News Daily News

Bradycardia Guidelines Offer Tips on Diagnosis, Management

Caitlin E. Cox

November 08, 2018

News Daily News

NIH Presses Pause on Cardiac Stem Cell Trial, Further Muddying a Murky Field

Shelley Wood

November 02, 2018

Advertisement

FDA Approves the Optimizer Smart Implantable Pulse Generator for Heart Failure

CardioMEMS Postapproval Study Linked to Reduction in Heart Failure Hospitalizations at 1 Year

Live From New Orleans: Days 2 and 3 at ACC 2019

COAPT Echo Substudy in HF Patients With Mitral Regurgitation Offers New Answers, and More Questions

HF Admissions Decline, Non-CV Hospitalizations Rise After TAVR

How HF Drugs Help and Harm Female Patients: A Call for Sex-Specific Reporting

Amgen, Cytokinetics And Servier Announce Start Of METEORIC-HF, The Second Phase 3 Clinical Trial Of Omecamtiv Mecarbil In Patients With Heart Failure

‘Watchful Waiting’ Tied to Poor Long-term Outcomes in Patients With Severe AR, Analysis Suggests

None of the Usual Suspects? Troponin Elevation Still Warrants Attention

Artificial Intelligence From ECGs May ID Asymptomatic LV Dysfunction

MitraClip Analysis Highlights Questions of Patient Selection in Functional MR

Top News in Heart Failure: 2018

More Registry Data Show No Survival Advantage for Impella in Acute MI With Cardiogenic Shock

Could RAS-Inhibitor Prescription After TAVR Improve 1-Year Outcomes?

EMPA-HEART Offers Mechanistic Clues for Empagliflozin’s Cardiac Benefits

Rivaroxaban Lowers Thromboembolic Risk in HF Patients: COMMANDER HF

Remission, Not Cure: No Weaning Off Meds for Dilated Cardiomyopathy Patients, Says TRED-HF

PIONEER-HF: Sacubitril/Valsartan Safe and Effective in Acute Decompensated Heart Failure

Bradycardia Guidelines Offer Tips on Diagnosis, Management

NIH Presses Pause on Cardiac Stem Cell Trial, Further Muddying a Murky Field

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content